146 related articles for article (PubMed ID: 15831442)
1. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
Miyata N; Seki T; Tanaka Y; Omura T; Taniguchi K; Doi M; Bandou K; Kametani S; Sato M; Okuyama S; Cambj-Sapunar L; Harder DR; Roman RJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):77-85. PubMed ID: 15831442
[TBL] [Abstract][Full Text] [Related]
2. Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion.
Renic M; Klaus JA; Omura T; Kawashima N; Onishi M; Miyata N; Koehler RC; Harder DR; Roman RJ
J Cereb Blood Flow Metab; 2009 Mar; 29(3):629-39. PubMed ID: 19107134
[TBL] [Abstract][Full Text] [Related]
3. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE.
Takeuchi K; Renic M; Bohman QC; Harder DR; Miyata N; Roman RJ
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2203-11. PubMed ID: 15964920
[TBL] [Abstract][Full Text] [Related]
4. Reversal of delayed vasospasm by TS-011 in the dual hemorrhage dog model of subarachnoid hemorrhage.
Hacein-Bey L; Harder DR; Meier HT; Varelas PN; Miyata N; Lauer KK; Cusick JF; Roman RJ
AJNR Am J Neuroradiol; 2006; 27(6):1350-4. PubMed ID: 16775295
[TBL] [Abstract][Full Text] [Related]
5. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Dunn KM; Renic M; Flasch AK; Harder DR; Falck J; Roman RJ
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2455-65. PubMed ID: 18952718
[TBL] [Abstract][Full Text] [Related]
6. Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.
Tanaka Y; Omura T; Fukasawa M; Horiuchi N; Miyata N; Minagawa T; Yoshida S; Nakaike S
Neurosci Res; 2007 Dec; 59(4):475-80. PubMed ID: 17933409
[TBL] [Abstract][Full Text] [Related]
7. Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury.
Omura T; Tanaka Y; Miyata N; Koizumi C; Sakurai T; Fukasawa M; Hachiuma K; Minagawa T; Susumu T; Yoshida S; Nakaike S; Okuyama S; Harder DR; Roman RJ
Stroke; 2006 May; 37(5):1307-13. PubMed ID: 16601220
[TBL] [Abstract][Full Text] [Related]
8. The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice.
Marumo T; Eto K; Wake H; Omura T; Nabekura J
Br J Pharmacol; 2010 Nov; 161(6):1391-402. PubMed ID: 20735406
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH.
Takeuchi K; Miyata N; Renic M; Harder DR; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R84-9. PubMed ID: 16166205
[TBL] [Abstract][Full Text] [Related]
10. Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage.
Cambj-Sapunar L; Yu M; Harder DR; Roman RJ
Stroke; 2003 May; 34(5):1269-75. PubMed ID: 12677022
[TBL] [Abstract][Full Text] [Related]
11. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat.
Kehl F; Cambj-Sapunar L; Maier KG; Miyata N; Kametani S; Okamoto H; Hudetz AG; Schulte ML; Zagorac D; Harder DR; Roman RJ
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1556-65. PubMed ID: 11893593
[TBL] [Abstract][Full Text] [Related]
12. Characterization of blood pressure and renal function in chromosome 5 congenic strains of Dahl S rats.
Roman RJ; Hoagland KM; Lopez B; Kwitek AE; Garrett MR; Rapp JP; Lazar J; Jacob HJ; Sarkis A
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1463-71. PubMed ID: 16396943
[TBL] [Abstract][Full Text] [Related]
13. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone.
Yu M; Cambj-Sapunar L; Kehl F; Maier KG; Takeuchi K; Miyata N; Ishimoto T; Reddy LM; Falck JR; Gebremedhin D; Harder DR; Roman RJ
Eur J Pharmacol; 2004 Feb; 486(3):297-306. PubMed ID: 14985052
[TBL] [Abstract][Full Text] [Related]
14. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm.
Roman RJ; Renic M; Dunn KM; Takeuchi K; Hacein-Bey L
Neurol Res; 2006 Oct; 28(7):738-49. PubMed ID: 17164037
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR.
Su P; Kaushal KM; Kroetz DL
Am J Physiol; 1998 Aug; 275(2):R426-38. PubMed ID: 9688677
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia.
Poloyac SM; Zhang Y; Bies RR; Kochanek PM; Graham SH
J Cereb Blood Flow Metab; 2006 Dec; 26(12):1551-61. PubMed ID: 16570075
[TBL] [Abstract][Full Text] [Related]
17. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
18. Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
Liu Y; Li Y; Zhan M; Liu Y; Li Z; Li J; Cheng G; Teng G; Lu L
Brain Res; 2019 Apr; 1708():160-170. PubMed ID: 30571981
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.
Kawamura M; Kobashi Y; Tanaka H; Bohno-Mikami A; Hamada M; Ito Y; Hirata T; Ohara H; Kojima N; Koretsune H; Gunji E; Fukunaga T; Inatani S; Hasegawa Y; Suzuki A; Takahashi T; Kakinuma H
J Med Chem; 2022 Nov; 65(21):14599-14613. PubMed ID: 36318660
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
Zhang Y; Hoda MN; Zheng X; Li W; Luo P; Maddipati KR; Seki T; Ergul A; Wang MH
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R693-703. PubMed ID: 24990856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]